Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 4:18 PM View:  | Zai Lab Ltd (ZLAB) | 12-Aug-24 | Sale (Planned) | 3,115 | $16.20 | $50,463.00 | (13%) 23.53K to 20.42K | |
| 18-Jun-24 4:12 PM View: | Poseida Therapeutics, Inc. (PSTX) | 17-Jun-24 | Grant | 19,650 | -- | -- | 50% 39.3K to 58.95K | |
| 05-Apr-24 5:47 PM View: | Zai Lab Ltd (ZLAB) | 04-Apr-24 | Option Sale | 1,952 | $15.67 | $30,593.70 | (8%) 25.48K to 23.53K | |
| 05-Apr-24 5:47 PM View: | Zai Lab Ltd (ZLAB) | 03-Apr-24 | Option Exercise | 5,391 | $15.90 | $85,716.90 | 27% 20.09K to 25.48K | |
| 19-Mar-24 4:12 PM View: | Zai Lab Ltd (ZLAB) | 15-Mar-24 | Sale (Planned) | 2,544 | $18.86 | $47,979.80 | (11%) 22.64K to 20.09K | |
| 03-Jan-24 7:26 PM View: | Zai Lab Ltd (ZLAB) | 02-Jan-24 | Option Sale | 19,363 | $26.30 | $509,169.00 | (46%) 42.0K to 22.64K | |
| 03-Jan-24 7:26 PM View: | Zai Lab Ltd (ZLAB) | 29-Dec-23 | Option Exercise | 42,000 | -- | -- | 100% 0 to 42.0K | |
| 02-May-23 4:14 PM View: | Poseida Therapeutics, Inc. (PSTX) | 01-May-23 | Grant | 39,300 | -- | -- | 100% 0 to 39.3K | |
| 03-Jan-23 4:10 PM View: | Zai Lab Ltd (ZLAB) | 30-Dec-22 | Grant | 126,000 | -- | -- | 100% 0 to 126.0K | |
| 11-Oct-22 4:35 PM View: | Allogene Therapeutics, Inc. (ALLO) | 07-Oct-22 | Grant | 19,120 | -- | -- | 4% 531.29K to 550.41K | |
| 11-Oct-22 4:35 PM View: | Allogene Therapeutics, Inc. (ALLO) | 07-Oct-22 | Payment of Exercise | 8,464 | $11.83 | $100,099.00 | (2%) 550.41K to 541.95K | |
| 05-Oct-22 4:02 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Oct-22 | Payment of Exercise | 8,968 | $11.06 | $99,201.30 | (2%) 540.26K to 531.29K | (10%) |
| 02-Aug-22 5:40 PM View: | Allogene Therapeutics, Inc. (ALLO) | 02-Aug-22 | Market Sale (Planned) | 2,000 | $11.97 | $23,940.00 | (< 1%) 542.26K to 540.26K | (2%) |
| 06-Jul-22 4:16 PM View: | Allogene Therapeutics, Inc. (ALLO) | 05-Jul-22 | Market Sale (Planned) | 2,000 | $11.44 | $22,880.00 | (< 1%) 544.26K to 542.26K | (7%) |
| 22-Jun-22 4:47 PM View: | Allogene Therapeutics, Inc. (ALLO) | 21-Jun-22 | Market Sale (Planned) | 2,000 | $11.18 | $22,360.00 | (< 1%) 546.26K to 544.26K | (9%) |
| 19-May-22 5:40 PM View: | Allogene Therapeutics, Inc. (ALLO) | 19-May-22 | Sale | 11,500 | $7.40 | $85,092.00 | (2%) 557.76K to 546.26K | |
| 25-Mar-22 5:52 PM View: | Allogene Therapeutics, Inc. (ALLO) | 23-Mar-22 | Grant | 237,358 | -- | -- | 74% 320.12K to 557.48K | |
| 17-Mar-22 5:59 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-22 | Sale | 5,169 | $7.71 | $39,847.80 | (2%) 325.29K to 320.12K | |
| 04-Oct-21 5:55 PM View: | Allogene Therapeutics, Inc. (ALLO) | 01-Oct-21 | Market Sale | 11,507 | $24.35 | $280,185.00 | (3%) 335.44K to 323.93K | (< 1%) |
| 20-May-21 5:22 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-May-21 | Grant | 200,534 | -- | -- | 149% 134.9K to 335.44K | |
| 30-Mar-21 4:47 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Mar-21 | Grant | 24,866 | -- | -- | 23% 110.03K to 134.9K | |
| 17-Mar-21 5:01 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Sale | 2,798 | $38.05 | $106,471.00 | (2%) 112.83K to 110.03K | (< 1%) |
| 08-Oct-20 5:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 07-Oct-20 | Market Sale (Planned) | 16,538 | $39.40 | $651,514.00 | (13%) 128.22K to 111.68K | 30% |
| 02-Oct-20 4:40 PM View: | Allogene Therapeutics, Inc. (ALLO) | 01-Oct-20 | Market Sale | 9,752 | $36.37 | $354,662.00 | (7%) 137.97K to 128.22K | 24% |
| 20-Mar-20 4:37 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-Mar-20 | Grant | 30,800 | -- | -- | 29% 105.16K to 135.96K | |
| 05-Sep-19 4:44 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Sep-19 | Grant | 105,162 | -- | -- | 100% 0 to 105.16K | |
| 07-Aug-19 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 06-Aug-19 | Market Sale | 11,043 | $2.06 | $22,748.60 | (39%) 28.28K to 17.24K | (163%) |
| 16-Jan-19 9:31 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Jan-19 | Market Sale | 3,028 | $5.37 | $16,258.50 | (38%) 8.0K to 4.97K | (< 1%) |